Ignacio
Gil Bazo
Investigador ata 2022
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublicacións en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (1)
2023
-
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study
Journal of Clinical Oncology, Vol. 41, Núm. 14, pp. 2651-2660